Nicole Blauensteiner

Nicole Blauensteiner

Auto-generated profile, based on publicly available information

Nicole Blauensteiner

Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2023 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
Agata ChobotAgata Chobot
Agata Chobot
SLStefanie Lanzinger
Stefanie Lanzinger
HAHessa Al-Kandari
Hessa Al-Kandari
GAG. Todd Alonso
G. Todd Alonso
NBNicole Blauensteiner
Nicole Blauensteiner
KDKlemen Dovc
Klemen Dovc
This study aimed to provide a global insight into initiatives in type 1 diabetes care driven by the COVID-19 pandemic and associations with glycemic outcomes. An online questionnaire regarding diabetes care before and during the pandemic was sent to all centers (n=97, 66,985 youth with type 1 diabetes) active in the SWEET registry. Eighty-two responded, and 70 (42,798 youth with type 1 diabetes) had available data (from individuals with type 1 diabetes duration >3 months, aged ≤21 years) for all 4 years from 2018 to 2021. Statistical models were adjusted, among others, for technology use. Sixty-five centers provided telemedicine during COVID-19. Among those centers naive to telemedicine before the pandemic (n=22), four continued only face-to-face visits. Centers that transitioned partially to telemedicine (n=32) showed a steady increase in HbA1c between 2018 and 2021 (p<0.001). Those that transitioned mainly to telemedicine (n=33%) improved HbA1c in 2021 compared to 2018 (p<0.001). Changes to models of care delivery driven by the pandemic showed significant associations with HbA1c shortly after the pandemic outbreak and 2 years of follow-up. The association appeared independent of the concomitant increase in technology use among youth with type 1 diabetes.